
Taysha Gene Therapies TSHA
€ 4.01
0.11%
Taysha Gene Therapies EV/EBITDA | TSHA
EV/EBITDA Jährlich Taysha Gene Therapies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.3 | -3.85 | -3.03 | -0.42 | -1.13 | -1.25 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.42 | -11.3 | -3.5 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Sol-Gel Technologies Ltd.
SLGL
|
-26.8 | $ 78.95 | 9.65 % | $ 220 M | ||
|
Silence Therapeutics plc
SLN
|
-48.1 | $ 10.14 | 0.78 % | $ 1.44 B | ||
|
SELLAS Life Sciences Group
SLS
|
-17.8 | $ 11.63 | 3.62 % | $ 1.27 B | ||
|
Summit Therapeutics
SMMT
|
81.3 K | $ 17.27 | 3.07 % | $ 12.9 B | ||
|
Syndax Pharmaceuticals
SNDX
|
-7.7 | $ 17.83 | 1.31 % | $ 1.54 B | ||
|
Soligenix
SNGX
|
-0.18 | $ 0.36 | 0.6 % | $ 1.87 M | ||
|
Sanofi
SNY
|
8.13 | $ 39.51 | 1.19 % | $ 48.2 B | ||
|
Spruce Biosciences
SPRB
|
-0.252 | $ 45.42 | 2.1 % | $ 34.8 M | ||
|
Spero Therapeutics
SPRO
|
16.2 | $ 1.16 | 4.13 % | $ 65 M | ||
|
Sarepta Therapeutics
SRPT
|
-4.66 | $ 17.49 | 0.7 % | $ 1.75 B | ||
|
Scholar Rock Holding Corporation
SRRK
|
-12.8 | $ 43.4 | 1.41 % | $ 4.98 B | ||
|
Stoke Therapeutics
STOK
|
-106 | $ 25.32 | 0.8 % | $ 1.5 B | ||
|
Sutro Biopharma
STRO
|
-2.84 | $ 15.13 | 0.23 % | $ 129 M | ||
|
Shattuck Labs
STTK
|
-6.35 | $ 6.5 | 1.04 % | $ 452 M | ||
|
Supernus Pharmaceuticals
SUPN
|
115 | $ 42.76 | 0.9 % | $ 2.41 B | ||
|
Sesen Bio
SESN
|
-1.13 | - | 7.29 % | $ 127 M | ||
|
Savara
SVRA
|
-9.6 | $ 4.78 | 0.1 % | $ 1.06 B | ||
|
China SXT Pharmaceuticals
SXTC
|
3.12 | $ 2.08 | 1.99 % | $ 1.41 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
20.3 | $ 17.81 | 0.08 % | $ 28.1 B | ||
|
Protara Therapeutics
TARA
|
-3.24 | $ 2.63 | 0.36 % | $ 113 M | ||
|
Tarsus Pharmaceuticals
TARS
|
-42.1 | $ 74.46 | 1.99 % | $ 3.11 B | ||
|
Bio-Techne Corporation
TECH
|
31.6 | $ 72.58 | 0.25 % | $ 11.3 B | ||
|
Tenax Therapeutics
TENX
|
-8.49 | $ 1.96 | 2.59 % | $ 76.9 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
22.4 | $ 39.66 | 0.33 % | $ 45.4 B | ||
|
TG Therapeutics
TGTX
|
37.9 | $ 53.91 | 0.12 % | $ 7.78 B | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
0.497 | $ 8.07 | 0.54 % | $ 68.7 M | ||
|
Trevi Therapeutics
TRVI
|
-30.5 | $ 13.72 | 0.99 % | $ 1.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
-8.98 | $ 42.78 | 3.33 % | $ 2.06 B | ||
|
United Therapeutics Corporation
UTHR
|
14.4 | $ 536.4 | 0.37 % | $ 23.8 B | ||
|
Vericel Corporation
VCEL
|
84.9 | $ 41.07 | 2.29 % | $ 2.07 B | ||
|
Veracyte
VCYT
|
35.1 | $ 47.67 | 4.06 % | $ 3.75 B | ||
|
Vir Biotechnology
VIR
|
-2.19 | $ 11.78 | 5.46 % | $ 1.63 B | ||
|
Viking Therapeutics
VKTX
|
-7.87 | $ 29.28 | 0.36 % | $ 3.3 B | ||
|
Vanda Pharmaceuticals
VNDA
|
-2.9 | $ 4.58 | 0.51 % | $ 270 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-4.89 | $ 4.31 | 0.21 % | $ 45.9 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
29 | $ 503.5 | 0.07 % | $ 129 B | ||
|
Verastem
VSTM
|
-2.28 | $ 8.0 | 3.9 % | $ 554 M | ||
|
VistaGen Therapeutics
VTGN
|
-0.055 | $ 0.26 | 0.21 % | $ 9.9 M | ||
|
vTv Therapeutics
VTVT
|
1.94 | $ 30.33 | 0.59 % | $ 120 M | ||
|
Voyager Therapeutics
VYGR
|
-1.82 | $ 2.46 | 0.41 % | $ 144 M | ||
|
Wave Life Sciences Ltd.
WVE
|
-9.94 | $ 3.75 | 0.66 % | $ 632 M | ||
|
Xenetic Biosciences
XBIO
|
0.897 | $ 2.2 | 0.45 % | $ 3.74 M | ||
|
XBiotech
XBIT
|
0.841 | $ 2.18 | 0.23 % | $ 66.5 M | ||
|
Exicure
XCUR
|
-8.87 | $ 1.07 | 3.48 % | $ 6.74 M | ||
|
Xenon Pharmaceuticals
XENE
|
-6.03 | $ 37.57 | 4.68 % | $ 2.98 B | ||
|
Xeris Pharmaceuticals
XERS
|
46.8 | $ 10.13 | 11.56 % | $ 1.63 B | ||
|
X4 Pharmaceuticals
XFOR
|
-0.771 | $ 2.9 | 2.47 % | $ 123 M | ||
|
Xencor
XNCR
|
-6.45 | $ 25.63 | 3.18 % | $ 1.9 B | ||
|
22nd Century Group
XXII
|
-0.173 | $ 0.91 | 2.13 % | $ 168 K |